SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-19-000430
Filing Date
2019-11-13
Accepted
2019-11-13 21:03:35
Documents
1
Period of Report
2019-11-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 17034
  Complete submission text file 0001192482-19-000430.txt   19215
Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Reporting) CIK: 0001497725 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39130 | Film No.: 191216010

Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Issuer) CIK: 0001561921 (see all company filings)

IRS No.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address CIRA CENTER 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address CIRA CENTER 2929 ARCH STREET PHILADELPHIA PA 19104 215-988-6800
Quaker BioVentures Capital II, L.P. (Reporting) CIK: 0001583083 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39130 | Film No.: 191216011